Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6195 USD | +1.56% | -7.55% | +83.45% |
May. 09 | Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.45% | 10.65M | |
+38.60% | 50.93B | |
-0.36% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.87% | 26.02B | |
-22.48% | 18.9B | |
+8.13% | 13.21B | |
+24.82% | 12.17B | |
+30.13% | 12.16B |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Maxim Group Downgrades Monopar Therapeutics to Hold From Buy